2026 ICD-10-CM Diagnosis Code P59.3Neonatal jaundice from breast milk inhibitor
ICD-10-CM Codes›P00–P96›P50-P61›P59
- Billable — Valid for Submission
- Not Chronic
P59.3 is a billable ICD-10-CM diagnosis code for neonatal jaundice from breast milk inhibitor. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 795. Coders also document this condition as neonatal jaundice due to delayed conjugation. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Hemolytic jaundice and perinatal jaundice.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Neonatal jaundice due to delayed conjugation
- Neonatal jaundice due to delayed conjugation from breast milk inhibitor
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Jaundice
Jaundice causes your skin and the whites of your eyes to turn yellow. Too much bilirubin causes jaundice. Bilirubin is a yellow chemical in hemoglobin, the substance that carries oxygen in your red blood cells. As red blood cells break down, your body builds new cells to replace them. The old ones are processed by the liver.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert P59.3 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About P59.3Overview
What is the ICD-10 code for neonatal jaundice from breast milk inhibitor?
The ICD-10-CM code for neonatal jaundice from breast milk inhibitor is P59.3 (sometimes written as P593). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is P59.3 (Neonatal jaundice from other and unspecified causes) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report neonatal jaundice from breast milk inhibitor on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does P59.3 group to?
When neonatal jaundice from breast milk inhibitor is the principal diagnosis on an inpatient stay, it groups to MS-DRG 795 (normal Newborn), which carries a relative weight of 0.1998. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of P59.3?
Under the General Equivalence Mappings, neonatal jaundice from breast milk inhibitor converts to ICD-9-CM 774.39 (delay conjugat jaund NEC). The mapping is approximate, so confirm the match fits the documentation.